Forza Innovations Inc
Forza Innovations Inc. engages in the health-tech wearable performance business. It offers WarmUp series product line, including J4 Sport, J4 X, and J4 Fitbelt that are wearable back compression devices that are used to relax, warmup, loosen, or relax stiff and sore muscles. The company was formerly known as Genesys Industries, Inc. and changed its name to Forza Innovations Inc. in June 2021. For… Read more
Forza Innovations Inc (FORZ) - Net Assets
Latest net assets as of March 2024: $-4.26 Million USD
Based on the latest financial reports, Forza Innovations Inc (FORZ) has net assets worth $-4.26 Million USD as of March 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($73.40K) and total liabilities ($4.33 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-4.26 Million |
| % of Total Assets | -5800.36% |
| Annual Growth Rate | N/A |
| 5-Year Change | -7727.93% |
| 10-Year Change | N/A |
| Growth Volatility | 231.07 |
Forza Innovations Inc - Net Assets Trend (2016–2024)
This chart illustrates how Forza Innovations Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Forza Innovations Inc (2016–2024)
The table below shows the annual net assets of Forza Innovations Inc from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | $-4.61 Million | 0.00% |
| 2023-06-30 | $-4.61 Million | -247.20% |
| 2022-06-30 | $-1.33 Million | -369.43% |
| 2021-06-30 | $-282.73K | -568.02% |
| 2020-06-30 | $60.41K | -38.62% |
| 2019-06-30 | $98.42K | +2375.56% |
| 2018-06-30 | $-4.33K | -129.90% |
| 2017-06-30 | $14.47K | +251.98% |
| 2016-06-30 | $-9.52K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Forza Innovations Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1094132500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.42 Million | % |
| Other Comprehensive Income | $26.53K | % |
| Other Components | $4.89 Million | % |
| Total Equity | $-4.61 Million | 100.00% |
Forza Innovations Inc Competitors by Market Cap
The table below lists competitors of Forza Innovations Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SANDY SPRING BANCRP
BE:SD2
|
$236.01K |
|
EL Ezz Aldekhela Steel - Alexandria
EGX:IRAX
|
$236.05K |
|
Florentaise SA
PA:ALFLO
|
$236.06K |
|
Vertical Capital Income Fund
NYSE:CCIA
|
$236.09K |
|
Waverley Pharma Inc
V:WAVE
|
$235.88K |
|
Nissan
TA:NISA
|
$235.73K |
|
Craven House Capital PLC
LSE:CRV
|
$235.69K |
|
Sound Point Meridian Capital, Inc.
PINK:SPMCP
|
$235.68K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Forza Innovations Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -4,608,030 to -4,608,030, a change of 0.
- Net loss of 4,755,706 reduced equity.
- Other comprehensive income increased equity by 26,531.
- Other factors increased equity by 4,729,175.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-4.76 Million | -103.2% |
| Other Comprehensive Income | $26.53K | +0.58% |
| Other Changes | $4.73 Million | +102.63% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Forza Innovations Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-06-30 | $0.00 | $0.00 | x |
| 2017-06-30 | $0.00 | $0.00 | x |
| 2018-06-30 | $0.00 | $0.00 | x |
| 2019-06-30 | $0.00 | $0.00 | x |
| 2020-06-30 | $0.00 | $0.00 | x |
| 2021-06-30 | $-0.01 | $0.00 | x |
| 2022-06-30 | $0.00 | $0.00 | x |
| 2023-06-30 | $0.00 | $0.00 | x |
| 2024-06-30 | $-0.01 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Forza Innovations Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4149.98%
- • Asset Turnover: 1.25x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-83.86%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-7.56K |
| 2017 | -327.74% | -3494.03% | 0.06x | 1.48x | $-48.86K |
| 2018 | 0.00% | -32.21% | 0.45x | 0.00x | $-75.86K |
| 2019 | 104.39% | 13.36% | 1.23x | 6.35x | $92.90K |
| 2020 | -531.38% | -53.02% | 0.71x | 14.04x | $-327.05K |
| 2021 | 0.00% | -525.52% | 4.39x | 0.00x | $-3.15 Million |
| 2022 | 0.00% | -10438.36% | 0.06x | 0.00x | $-2.57 Million |
| 2023 | 0.00% | -4149.98% | 1.25x | 0.00x | $-4.29 Million |
| 2024 | 0.00% | -4149.98% | 1.25x | 0.00x | $-4.29 Million |
Industry Comparison
This section compares Forza Innovations Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Forza Innovations Inc (FORZ) | $-4.26 Million | 0.00% | N/A | $235.89K |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |